Surgery Versus Stereotactic Radiosurgery for Single Synchronous Brain Metastasis from Non-Small Cell Lung Cancer

被引:0
作者
Hui LIShengcai HOUBin HUTong LIYang Wang Jinbai MiaoBin YouYili Fu Department of Thoracic SurgeryBeijing Chaoyang HospitalCapital Medical University Beijing China [100020 ]
机构
关键词
Non-small cell lung cancer(NSCLC); Synchronous brain metastasis; Surgery; Stereotactic radiosurgery(SRS);
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
Objective:The aim of this study is to compare the effectiveness of surgery with stereotactic radiosurgery(SRS) for patients with a single synchronous brain metastasis from successfully treated non-small cell lung cancer. Methods:Between 1995 and 2002,53 patients underwent resection of both primary non-small cell lung cancer and the associated single brain metastasis. There were 33 men and 20 women with a mean age of 57 years(range,32-85 years). At the time of diagnosis,42 patients experienced lung cancer related symptoms,whereas 11 patients experienced brain metastases-related symptoms. 42 patients had received thoracic surgery first,and 11 patients had undergone neurosurgery or radiosurgery first. Pneumonectomy was performed in 9 out of 42 patients(21.4%),lobectomies in 30(71.4%),and wedge resection in 3(7.2%). 48 patients(90.5%) underwent complete lymphadenectomy. 35 patients underwent brain metastasectomy. 18 underwent SRS. Results:There was no postoperative mortality and severe complications after either lung or brain surgery. Histology showed 34 adenocarcinomas,16 squamous cell carcinomas,and 3 large cell lung cancers. 15 patients(28.3%) had no evidence of lymph node metastases(N0),20 patients(37.7%) had hilar metastases(N1),and 18 patients(34%) had mediastinal metastases(N2). The 1-,2-,3-and 5-year overall survival rates were 49%,19%,10%,and 5%,respectively. The corresponding data for neurosurgery group were 55%,17%,11%,and 6%,respectively. The median survival time was 13 months. For SRS group the corresponding data were 44.8%,20.9% 10.5%,and 2%,respectively. The median survival time was 14 months. The differences between the two groups were not significant(P>0.05). In lymph node negative patients(N0),the overall 5-year survival rate was 10%,as compared with a 1% survival rate in patients with lymph node metastases(N1-2). The difference was significant(P<0.01). For adenocarcinomas,the 5-year survival rate was 5%. The correspondent data for squamous cell lung cancers was 3%. The difference was not significant(P>0.05). Conclusion:Although the overall survival rate for patients who have brain metastases from NSCLC is poor,surgical resection or radiosurgery may be beneficial in a select group of patients with synchronous brain metastases and lung cancer without lymph node metastases.
引用
收藏
页码:56 / 60
页数:5
相关论文
共 50 条
[41]   Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis [J].
Byeon, Seonggyu ;
Ham, Jun Soo ;
Sun, Jong-Mu ;
Lee, Se-Hoon ;
Ahn, Jin Seok ;
Park, Keunchil ;
Ahn, Myung-Ju .
MEDICAL ONCOLOGY, 2016, 33 (08)
[42]   Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis [J].
Seonggyu Byeon ;
Jun Soo Ham ;
Jong-Mu Sun ;
Se-Hoon Lee ;
Jin Seok Ahn ;
Keunchil Park ;
Myung-Ju Ahn .
Medical Oncology, 2016, 33
[43]   Advances in stereotactic body radiation therapy for early stage non-small cell lung cancer [J].
Brown, Andrea M. ;
Mak, Raymond H. ;
Kann, Benjamin H. .
CURRENT CHALLENGES IN THORACIC SURGERY, 2022, 4
[44]   Stereotactic radiotherapy for operable stage I non-small cell lung cancer [J].
Martin, E. ;
Nicolet, C. ;
Boisselier, P. ;
Khalifa, J. ;
Thureau, S. .
CANCER RADIOTHERAPIE, 2023, 27 (6-7) :648-652
[45]   History of non small cell lung cancer management: from surgery to stereotactic radiation therapy [J].
Bertho, A. ;
Dos Santos, M. ;
Francois, A. ;
Milliat, F. .
RADIOPROTECTION, 2020, 55 (03) :165-172
[46]   Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer [J].
de Ruiter, Julianne Cynthia ;
van Diessen, Judi Nani Annet ;
Smit, Egbert Frederik ;
van der Noort, Vincent ;
Damhuis, Ronald Alphons Maria ;
Hartemink, Koen Johan .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (03)
[47]   Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036) [J].
Wang, Hongsheng ;
Ou, Qiuxiang ;
Li, Delan ;
Qin, Tao ;
Bao, Hua ;
Hou, Xue ;
Wang, Kaicheng ;
Wang, Fang ;
Deng, Qianqian ;
Liang, Jianzhong ;
Zheng, Wei ;
Wu, Xue ;
Wang, Xiaonan ;
Shao, Yang W. ;
Mou, Yonggao ;
Chen, Likun .
CANCER, 2019, 125 (20) :3535-3544
[48]   Stereotactic Body Radiotherapy Versus Surgery for Early-Stage Non-Small-Cell Lung Cancer [J].
Li, Hui ;
Shen, Yefeng ;
Wu, Yuanzhou ;
Cai, Shaoru ;
Zhu, Yaru ;
Chen, Siping ;
Chen, Xin ;
Chen, Qunqing .
JOURNAL OF SURGICAL RESEARCH, 2019, 243 :346-353
[49]   Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery [J].
Hideyuki Maeda ;
Masato Kanzaki ;
Kei Sakamoto ;
Tamami Isaka ;
Kenji Yamazaki ;
Takamasa Onuki .
Surgery Today, 2017, 47 :284-292
[50]   Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery [J].
Maeda, Hideyuki ;
Kanzaki, Masato ;
Sakamoto, Kei ;
Isaka, Tamami ;
Yamazaki, Kenji ;
Onuki, Takamasa .
SURGERY TODAY, 2017, 47 (03) :284-292